Patent · US Expired

3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as antitumor agent

US5652234A · kind A · utility

0Cited by
0References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 6, 1995
Grant dateJul 29, 1997
Priority date
Expiry dateOct 6, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the use of 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivatives of formula (I) or a pharmaceutically acceptable salt thereof, as antitumor agents. ##STR1## Wherein R is: hydrogen or COOR.sub.2 wherein R.sub.2 is C.sub.1 -C.sub.3 alkyl group which may be substituted with aryl group. Wherein R.sub.1 is: PA1 hydrogen or C.sub.1 -C.sub.3 alkyl group which may be substituted with one or two aryl groups.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.